Extrapyramidal symptoms following administration of oral perphenazine 4 or 8 mg: An 11-year retrospective analysis

@article{Henao2014ExtrapyramidalSF,
  title={Extrapyramidal symptoms following administration of oral perphenazine 4 or 8 mg: An 11-year retrospective analysis},
  author={J. Henao and K. Peperzak and A. Lichvar and S. Orebaugh and S. Skledar and Michael A Pippi and B. Williams},
  journal={European Journal of Anaesthesiology},
  year={2014},
  volume={31},
  pages={231–235}
}
  • J. Henao, K. Peperzak, +4 authors B. Williams
  • Published 2014
  • Medicine
  • European Journal of Anaesthesiology
  • BACKGROUND Perphenazine is a treatment option in postoperative nausea and vomiting (PONV) prophylaxis. Chronic administration and high dose are known to cause extrapyramidal system (EPS) dysfunction at a frequency of 8%, but the incidence of acute EPS after a single 4 or 8 mg dose is unknown. OBJECTIVE A retrospective analysis of patient medication billing data and departmental quality records was performed (January 2001 to 10 July 2012) to identify patients who experienced EPS dysfunction… CONTINUE READING
    8 Citations
    Oral Perphenazine 8 mg: A Low-Cost, Efficacious Antiemetic Option
    Chapter 6 - Antipsychotic Drugs

    References

    SHOWING 1-10 OF 12 REFERENCES
    Extrapyramidal Symptoms with Atypical Antipsychotics
    • 152
    • PDF
    Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
    • 4,788
    • PDF
    A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
    • 1,239
    • PDF
    Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
    • N Engl J Med
    • 2005